Imaging reporter genes can provide valuable, longitudinal information on the biodistribution, 23 growth and survival of engineered cells in preclinical models and patients. A translational 24 bottleneck to using reporter genes in patients is the necessity to engineer cells with randomly-25 integrating vectors. CRISPR/Cas9 targeted knock-in of reporter genes at a genomic safe harbor 26 locus such as adeno-associated virus integration site 1 (AAVS1) may overcome these safety 27 concerns. Here, we built Homology Independent Targeted Integration (HITI) CRISPR/Cas9 28 minicircle donors for precise AAVS1-targeted simultaneous knock-in of fluorescence, 29 bioluminescence, and MRI (Oatp1a1) reporter genes. Our results showed greater knock-in 30 efficiency at the AAVS1 site using HITI vectors compared to homology-directed repair donor 31 vectors. Characterization of select HITI clones demonstrated functional fluorescence and 32 bioluminescence reporter activity as well as significantly increased Oatp1a1-mediated uptake of 33 the clinically-approved MRI agent gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid. 34
Introduction
safe and site-specific manner. The application of such editing tools would allow for longitudinal 75 cell tracking to confirm that the cells are performing their intended role, as well as to detect any 76 ectopic growths or misplaced targeting at the earliest time point. This will ultimately give the 77 clinician greater control and confidence in the outcomes of the targeted therapy. 78 79 Genomic safe harbors can incorporate exogenous pieces of DNA and permit their predictable 80 function, but do not cause alterations to the host genome, nor pose a risk to the host cell or 81 organism 23 . Several studies have successfully used genome editing tools such as zinc finger 82 nucleases (ZFN) and transcription activator-like effector nucleases (TALENs) to incorporate 83 reporter genes at the adeno-associated virus integration site 1 (AAVS1) safe harbor locus, with 84 no detrimental effects [24] [25] [26] . Although ZFN and TALENs have shown great promise as targeted 85 DNA editors, they are time consuming, expensive and challenging to engineer as new nuclease 86 sequences must be generated for every new genomic target. Alternatively, clustered regularly 87 interspaced short palindromic repeat/Cas9 (CRISPR/Cas9), which was developed by several 88 groups in 2013 27-30 , allows for quicker, cheaper and easier-to-design human genome editing. 89 CRISPR/Cas9 utilizes short guide RNAs (gRNAs; ~20bp in length) to direct the Cas9 90 endonuclease to a specific genomic locus and induce a double stranded DNA break. Both the 91 Cas9 enzyme and gRNA sequences can be encoded in a single plasmid and when co-transfected 92 with a donor DNA plasmid can lead to higher homology directed repair (HDR) knock-in 93 efficiency than previous editing tools 31 . We have previously described the first CRISPR-Cas9 94 system for AAVS1 integration of donor constructs containing an antibiotic resistance selection 95 gene and both fluorescence (tdTomato) and bioluminescence (Firefly luciferase) reporter 96 genes 32 . We were able to confirm the correct and stable integration of donor DNA at the AAVS1 97 site and functional reporter gene expression in vivo. However, some of the limitations of our 98 study include (i) the low editing efficiency (~3.8%) of HEK-293T cells; (ii) the use of large 99 CRISPR/Cas9 and donor DNA plasmids that contained bacterial and antibiotic resistance genes -100 which limit transfection efficiency and would have associated safety concerns for clinical 101 translation; and (iii) the lack of a translationally relevant reporter gene. In this study, we aimed to 102 address these limitations by improving the efficiency and clinical safety of reporter gene 103 integration at the AAVS1 safe harbor site and included a translationally relevant reporter gene. 104
We posited that the low editing efficiency of our first system was due in part to reduced 106 transfection and knock-in efficiency, which is common with larger DNA plasmids, and the use of 107 the HDR repair pathway for integration, which is intrinsically inefficient and not readily 108 accessible to non-dividing cells 33 . In contrast to HDR-mediated DNA repair, the non-109 homologous end joining (NHEJ) pathway is active in both proliferating and non-proliferating 110 cells and is generally considered more efficient than HDR in mammalian cells 34 . Recent studies 111 have shown that by designing a CRISPR/Cas9 system that includes the same gRNA cut site in 112 the donor vector as the genomic target site, the NHEJ repair pathway will more efficiently lead 113 to transgene integration in zebrafish 35 and mammalian cells 36, 37 . Suzuki et al. refer to this 114 mechanism as homology independent targeted integration (HITI), which is expected to lead to 115 increased insertion in the forward rather than the reverse direction, as intact gRNA target 116 sequences will be preserved in the latter 38 . Therefore, we postulated that HITI will increase the 117 efficiency of reporter gene integration at the AAVS1 site ( Figure 1A ), compared to HDR. To 118 address the problem of size and bacterial/antibiotic resistance genes in plasmids, our group and 119
Suzuki et al. 38 , previously designed minicircles (MC) to express genes of interest 39,40 . First 120 described by Darquet et al. 41 , MCs lack the bacterial backbone and antibiotic resistance genes 121 that would otherwise compromise biosafety and clinical translation. In addition, the removal of 122 the prokaryotic backbone also greatly reduces the size of the vector, thus improving transfection 123 efficiency or providing space for the inclusion of other transgenes. To that end, we aimed to 124 improve on our previous work by including a translationally relevant reporter gene in a multi-125 modality imaging HITI MC donor. We determined that the rat organic-anion-transporting 126 polypeptide 1A1 (Oatp1a1) gene was an ideal candidate. Oatp1a1 is a positive contrast magnetic 127 resonance imaging (MRI) reporter gene due to its ability to uptake a clinically approved, liver-128 specific paramagnetic contrast agent called gadolinium ethoxybenzyl diethylenetriamine 129 pentaacetic acid (Gd-EOB-DTPA; Primovist/Eovist) 42 . We have previously shown that Oatp1a1 130 is a sensitive, quantitative, MRI reporter for 3-dimensional cancer cell distribution in vivo 43 . The 131 AAVS1-MC) and pCas9-scrambledRNA-zsG-MC (Cas9-scrambled-MC) parental plasmids 140 originated from pCas-Guide-AAVS1 and pCas-Guide-Scrambled plasmids purchased from 141
Origene (Maryland, USA). The Cas9 enzyme and guide RNA sequences were cloned between 142 attB and attP recombination sites in a minicircle bacterial backbone containing a ZsGreen (zsG) 143 fluorescence reporter driven by the elongation factor 1- promoter (hEF1). The AAVS1-HDR-144
tdT-Fluc2-Oatp1a1-MC (HDR-MC) construct was derived from an HDR vector lacking the 145 Oatp1a1 gene as we described previously 32 . This plasmid is driven by the hEF1 promoter, 146 expresses tdTomato (tdT), firefly luciferase (Fluc2) and Organic anion transporting polypeptide 147 1a1 (Oatp1a1) using a self-cleaving 2a peptide system. For improved expression, the plasmids 148 also contain the woodchuck hepatitis virus post-transcriptional regulatory element (WPRE) 149 followed by the human growth hormone polyadenylation signal (hGH polyA). The HDR plasmid 150 contains the left and right homologous arms (RHA:527bp, LHA:481bp) that are complementary 151 to the region flanking the AAVS1 cut site; the homologous arms were obtained from the 152 pAAVS1-puroDNR plasmid from Origene (Maryland, USA). The Oatp1a1 gene was added 153 through PCR amplification from a previously made vector we constructed using 154 PGK_Straw_E2A_Oatp1a1 (a kind gift from Dr. Kevin Brindle's laboratory; University of 155 Cambridge). Using the HDR-MC parental plasmid as the template, we generated the pAAVS1-156 HITI-tdT-Fluc2-Oatp1a1-MC (HITI-MC) parental plasmid using the In-Fusion cloning kit from 157 Clontech (Takara Bio, California, USA). Using restriction enzyme digestion, we extracted the 158 bacterial backbone and minicircle recombination sites and then extracted the three reporter genes 159 (without the homologous arms); tdT, Fluc2 and Oatp1a1 from the HDR-MC construct using 160 PCR. However, for HITI functionality we designed our primers to also include a 23 bp extension 161 (5'-GTTAATGTGGCTCTGGTTCTGGG-3') downstream of the polyA sequence, which 162 incorporates the same cut site and protospacer adjacent motif (PAM) sequence for our AAVS1 163 gRNA which allows for Cas9 cutting of both the MC and genomic DNA. picked 24 hrs after transformation, grown in 6 ml of lysogeny broth (LB) with kanamycin for 6 170 hrs at 37 o C, followed by growth in terrific broth (TB) for 12 hrs at 37 o C. To induce expression of 171 the phiC31 integrase for MC production via attB and attP recombination, 100 ml of LB broth 172 together with 100 µl of 20% arabinose induction solution (System Biosciences, Palo Alto, CA, 173 USA) and 4 ml of 1N NaOH was added to the culture and grown for 5.5 hrs at 30°C. An 174 endotoxin-free maxi kit (Qiagen, Valencia, CA, USA) was used to purify both PP and MC. 175 In Vitro Fluorescence and Bioluminescence Imaging 228
The pooled and clonal cell populations were evaluated for tdTomato fluorescence expression on 229 an EVOS FL auto 2 microscope (ThermoFisher, Waltham, MA, USA). For BLI experiments, 230 varying cell numbers were plated in triplicates into black walled 96-well plates. D-luciferin (0.1 231 mg/ml; PerkinElmer, Waltham, MA, USA) was added to each well and images rapidly collected 232 on an IVIS Lumina XRMS In Vivo Imaging System (PerkinElmer) equipped with a cooled CCD 233 camera. Average radiance values in photons/sec/cm 2 /steradian were measured from regions of 234 interest drawn around each well using LivingImage software (PerkinElmer). 235
236
In Vitro Magnetic Resonance Imaging 237 Naïve and Oatp1a1-expressing cell clones (2×10 6 ) were seeded in T-175 flasks and grown for 3 238 days. Cells were incubated with media containing 6.4 mM Gd-EOB-DTPA or with media 239 containing an equivalent volume of PBS for 90 minutes at 37°C and 5% CO2. Cells were then 240 washed 3 times with PBS, trypsinized and pelleted in 0.2 mL Eppendorf tubes, and placed into a 241 2% agarose phantom mould that was incubated in a 37°C chamber for two hours to mimic body 242
temperature. MRI was performed on a 3-Tesla GE clinical MRI scanner (General Electric 243
Healthcare Discovery MR750 3.0 T, Milwaukee, WI, USA) and a 3.5-cm diameter birdcage RF In Vivo Bioluminescence Imaging 269 BLI was performed on the same IVIS Lumina XRMS system described for in vitro imaging. 270
Mice were anesthetized with 2% isoflurane in 100% oxygen using a nose cone attached to an 271 activated carbon charcoal filter for passive scavenging and kept warm on a heated stage. BLI 272 images were acquired with automatic exposure times until the peak BLI signal was obtained (up 273 to 40 mins). Regions of interest were manually drawn using LivingImage software to measure 274 average radiance (photons/sec/cm 2 /sr). The peak average radiance was used for quantification for 275 each mouse. 276
277

In Vivo Magnetic Resonance Imaging and Quantification 278
All mouse MRI scans were performed with a custom-built gradient insert and a bespoke 5 cm 279 diameter solenoidal RF coil, as we described previously 43 . Mice were kept anaesthetized during 280 the scan with 2% isoflurane administered via a nose cone attached to the coil. T1-weighted 281 images were acquired using a spoiled gradient recalled acquisition in steady-state pulse sequence 282 using the following parameters: field of view, 50 mm; repetition time, 14.7 msec; echo time, 10.5 
). 298 299
Oatp1a1-induced Gd-EOB-DTPA uptake MRI and BLI sensitivity 300
To evaluate the cellular detection sensitivity of Oatp1a1 expressing cells with Gd-EOB-DTPA-301 enhanced MRI, nude mice were injected with 50 µl of cell suspensions in PBS containing 3x10 6 302 total cells/injection at the following ratios: 3x10 6 naïve cells alone; 10 4 PC3-HITI + 2.99x10 6 303 naïve cells; 10 5 PC3-HITI + 2.9x10 6 naïve cells; 10 6 PC3-HITI + 2x10 6 naïve cells; and 3x10 6 304 PC3-HITI cells alone, subcutaneously in 5 locations on the back/flank region. Immediately after 305 cell injections, 1.67 mmol/kg Gd-EOB-DTPA was injected into the tail vein and mice were 306 For experimental metastasis studies, 5x10 5 PC3 naïve or HITI engineered cells were injected into 316 the tail veins of NSG mice (N = 3). Tumour growth was tracked on a weekly basis with BLI, as 317 In this study, we designed our trimodal reporter gene system in MC constructs to reduce the size 337 and immunogenicity of our donor DNA and to remove antibiotic resistance genes. To compare 338 the efficiency of HDR vs HITI editing at the AAVS1 site, we designed two donor and two Cas9-339 expressing MCs, as shown in Figure 1B . The HDR and HITI constructs were engineered to 340 express tdTomato (tdT), firefly luciferase (Fluc2) and rat organic anion transporting polypeptide 341 1a1 (Oatp1a1) genes under the control of an EF1α promoter and 2A self cleaving peptide system 342 ( Figure 1B) . The HDR and HITI parental plasmids initially measured 11.9 kb and 10.4 kb in 343 size, which was then reduced to 7.9 kb and 6.4 kb when recombined into MCs, respectively, as 344 confirmed by agarose gel electrophoresis ( Figure 1C ). The HDR-MC was flanked by left and 345 right AAVS1 homologous arms either side of the AAVS1 genomic cut site, whereas the HITI 346 donor contained the same CRISPR/Cas9 cut site as the AAVS1 genomic site (Supp. Figure 1) . In 347 this instance, if the MC DNA inserted into the correct orientation at the AAVS1 site, the 348 CRISPR/Cas9 cut sites would be lost and the trimodal reporter genes would be stably integrated 349 into the genome (Supp. Figure 1) . The Cas9 expressing MCs were designed to contain the 350 necessary RNA scaffolding and gRNA sequences targeting the AAVS1 site or a scrambled 351 gRNA control, alongside a zsGreen (zsG) fluorescent reporter gene ( Figure 1B) . Both the pCas9- Figure 1D ) and grown for 48hrs. The cells were then FACs sorted for tdT+/zsG+ cells in order to 359 purify cells that were successfully co-transfected, and tdT fluorescence was then tracked every 7 360 days using flow cytometry (Supp. Figure 2A-B) . In two separate experimental groups, the cells 361 were then resorted 14 or 21 days later for tdT+/zsG-cells, to ensure that the cell populations had 362 not randomly integrated the Cas9-zsG MCs into the genome (Supp. Figure 2C ). Both PC3 363 experimental groups were resorted 14 days after the initial sort (and not 21 days later) due to 364 lower transfection rates. However, resorting the cells 14 or 21 days later had a negligible effect 365 on tdT+ cell populations across the timepoints. For almost all cell types there was a higher 366 percentage of tdT+ fluorescence cells at endpoint in the HITI-AAVS1 groups (pink shading, 367
Supp. Figure 2C ), suggesting better or more stable integration compared to HDR-AAVS1 368 groups. 369 370
Mixed cell population (MCP) integration and BLI analysis 371
We next performed junctional PCR analysis on extracted DNA samples to determine whether the 372 tdT+ MCPs had correctly incorporated the large, trimodal donor MCs into the AAVS1 site in the 373 right orientation (Supp. Figure 3A) . A correct integration band (1.4 kb) was detected for all 374 HITI-guideAAVS1 (HITIgA) engineered cells (very low transfection efficiency for PC3 cells 375 may explain why the integration band was weak) as well as a correct integration band (1.3 kb) 376
for HDR-guideAAVS1 (HDRgA) cells for 293T and HeLa MCPs. There were no integration 377 bands for the control naïve cells or cells engineered with scramble guide RNA (HITI/HDRgS). 378
Next, we performed in vitro BLI experiments to determine if the integrated reporter gene was 379 functioning in the MCPs. Varying numbers of each cell type were imaged with BLI after 380 addition of D-luciferin to visualize FLuc2 expression (Suppl Figure 3B ). In all cell types, there 381 was a positive correlation between BLI signal and cell number and, interestingly, a consistently 382 higher signal was seen in all cell types engineered with HITI-guideAAVS1 compared with HDR-383
guideAAVS1. 384
Next, we used clonal cell isolation to determine whether HITI or HDR was more efficient at 387 correctly integrating our large donor MCs at the AVVS1 site. Single cell tdT+ clones were 388 isolated from the 293T and PC3 MCPs into 96-well plates during a third FAC sort. We decided 389
to use the 293T cells as a proof-of-principle cell line and the PC3 cells as a relevant prostate 390 cancer model cell line, hence the HeLa cells were not included in studies from this point 391 onwards. PCR integration checks were performed on the 293T and PC3 clonal populations to 392 determine the efficiency of HITI-vs HDR-mediated reporter gene integration at the AAVS1 site 393 (Figure 2A-B ). The number of 293T clonal populations with correct integration was 11.8% 394 (4/34) for HDR-AAVS1 engineered cells and 36.1% (13/36) for HITI-AAVS1 clones ( Figure  395 2A-B). PC3 cells grew fewer colonies but showed zero integration at the AAVS1 site for tdT+ 396 HDR engineered cells (0/14), whereas 10.5% (2/19) of the HITI engineered colonies had correct 397 reporter gene integration, indicating that HITI was more efficient in both cell types. 398
399
In vitro reporter gene imaging 400
Next, we expanded single 293T and PC3 clonal populations that had correct integration bands 401 for further in vitro reporter gene functionality testing. Firstly, we confirmed tdT fluorescence for 402 both the 293T-HITI ( Figure 3A ) and PC3-HITI ( Figure 3G HITI cells were incubated with or without Gd-EOB-DTPA (6.4 mM) in normal media for 90 408 minutes, washed thoroughly, and pelleted before inserting into an agarose phantom. Inversion 409 recovery MRI was performed at 3 Tesla and 37°C, and spin-lattice relaxation rate (R1) maps 410 were generated ( Figure 3E, K) . Neither the naïve 293T/PC3 or untreated 293T-HITI and PC3-411 HITI cell populations exhibited any change in R1 rates ( Figure 3F , L). Only HITI clones 412 expressing Oatp1a1 had significantly increased R1 rates after Gd-EOB-DTPA incubation, with 413 ~10-fold increase for 293T-HITI cells (7.952 ± 0.87 s -1 ) compared with naïve, treated controls 414 (0.806 ± 0.038 s -1 ; n = 3, P < 0.001; Figure 3F ) and ~5-fold increase for PC3-HITI cells (3.426 ± 415 0.217 s -1 ) compared with naïve, treated controls (0.6402 ± 0.045 s -1 ; n = 3, P < 0.001; Figure  416 3L). 417 418
Oatp1a1 sensitivity in vivo 419
To investigate the MR detection limit of Oatp1a1-expressing cells we injected various 420 combinations of PC3-naïve and PC3-HITI cells at five sites subcutaneously on the backs of nude 421 mice (Figure 4 and Supp. Figure 4) . A total of 3x10 6 cells were injected per site with the 422 following number of PC3-HITI cells: 1 -0 (naïve cell only control); 2 -10 4 ; 3 -10 5 ; 4 -10 6 ; 5 -423 3x10 6 (HITI cell only control). Naïve cells were included with HITI cells so that each injection 424 contained a total of 3x10 6 /site. BLI signal intensity increased as PC3-HITI cell numbers 425 increased (representative mouse shown in Figure 4A ), with 10 6 and 3x10 6 HITI injections 426 showing significant signal increase above naïve background controls ( Figure 4B ). Transverse 427 MR images from the same mouse showed positive contrast at both the 10 6 and 3x10 6 HITI 428 injection sites 5 hours after Gd-EOB-DTPA injection ( Figure 4C ). Similar to the BLI data, these 429 sites also exhibited significantly higher contrast-to-noise ratios (CNR) than naïve controls 430 ( Figure 4D ). The 10 4 and 10 5 PC3-HITI injections were difficult to visualize on MRI, had no 431 discernible positive contrast and were, therefore, not measured. These data were consistent 432 across all three mice (see Supp. Figure 4) and showed that the very minimum number of 433
Oatp1a1-expressing cells we could detect with Gd-EOB-DTPA-based MR contrast was 10 6 cells 434 in a 50 l injection volume. 435 436 PC3-HITI Oatp1a1 tumour models for MRI detection 437
As a proof-of-principle that our HITI-engineered cells could show Gd-EOB-DTPA induced 438 positive MRI contrast in subcutaneous tumours, we injected 293T-naïve and 293T-HITI cells on 439 either flank of a nude mouse (Supp. Figure 5 ). For both cell types, the large masses were visible 440 on pre-contrast images but also showed noticeable positive contrast 20 minutes post-Gd-EOB-441 DTPA injection. However, 5 hours post-contrast, the naïve tumour had returned to pre-contrast 442 background levels, whereas the HITI tumour had very prominent positive contrast that also 443 showed heterogeneity within the tumour mass (Supp. Figure 5) , similarly to what we reported 444 previously 43 . 445
Moving into a more relevant cancer model, we next injected PC3-naïve and PC3-HITI clonal 447 cells subcutaneously on either flank of nude mice and followed BLI development over time 448 ( Figure 5 ). After only 11 days post-injection, before the tumours were visible or palpable, clear 449 positive contrast was observed for HITI engineered cells 5 hours after Gd-EOB-DTPA injection 450
( Figure 5A and Supp. Figure 6) . The same mice were then imaged at day 46 where the naïve 451 tumour was visible due to pooled Gd-EOB-DTPA after 20 minutes post-contrast injection. In a 452 similar fashion 5 hours post contrast, only the HITI engineered cells retained the Gd agent and 453 showed bright, positive contrast ( Figure 5B and Supp. Figure 7) . Quantification of CNR over 454 time showed a significant increase for the HITI tumours ( Figure 5C ). These data suggest that the 455 Oatp1a1 MRI reporter can detect tumour burden at stages where the tumours are not visible or 456 palpable and tumour growth can be tracked longitudinally with Gd-EOB-DTPA-enhanced MRI. 457
458
Finally, PC3-HITI cells were injected via the tail vein into NSG mice to investigate the ability of 459
Oatp1a1 as a reporter gene for visualizing metastases (Figure 6 ). Using BLI as a guide, we were 460 able to detect a Gd-EOB-DTPA-enhanced metastatic tumour in the liver of one mouse (Figure  461 6A). In this case, it was evident that a shadow in the liver (as seen in the pre-contrast MR image) 462 was likely the tumour, which the post-contrast image confirmed. However, in another mouse that 463 had BLI signal in the head region, a cluster of smaller PC3-HITI tumours was only identifiable 464 in post-contrast images ( Figure 6B As personalized medicine and CRISPR-editing become a reality in the clinic, there is a greater 469 need to 1) improve the efficiency, efficacy and safety of genetically engineered cell-therapies, 470
and 2) improve our understanding of disease progression and treatment response in preclinical 471 models of disease. Reporter gene-based imaging allows us to track the location, viability, growth 472 and efficacy of such treatments, and in preclinical models of cancer progression and treatment. In 473 this study, we have developed a non-viral vector-based engineering system for large DNA 474 multimodality reporter gene integration into the AAVS1 safe-harbour genomic locus. To 475 improve safety further, we utilized MCs as the DNA vector of choice, which eliminates bacterial 476 DNA contamination and antibiotic resistance genes. In addition, we showed that utilizing the non-homologous end joining (NHEJ) repair pathway with HITI could improve DNA editing 478 efficiency in human cells compared to the more commonly used HDR pathway. Finally, building 479 off our previous work 32 , we have engineered a trimodality reporter gene construct that contains a 480 clinically relevant MRI reporter, Oatp1a1, in addition to fluorescent and bioluminescent genes 481 which enabled cell sorting and non-invasive BLI/MRI of engineered cells in a pre-clinical cancer 482 model. 483
484
One of the major limitations of engineering cells with large, multimodality reporter gene DNA 485 plasmids is the reduced efficiency of both transfection and gene editing with increasing 486 construct/insert size [45] [46] [47] . In addition, the presence of bacterial and antibiotic resistance genes in 487 parental plasmids has the potential to exert immunological responses and raises safety concerns. 488
To circumvent these issues, we designed our study to use MCs, which removes the bacterial 489 backbone from parental plasmids and thus reduces the size of the DNA donor constructs. Using 490
MCs instead of parental plasmids allowed us to remove ~4 kb of unwanted DNA from our HDR 491 construct, with a further reduction of ~1.5 kb for the HITI MC when the homologous arm 492 sequences were replaced with a 20 bp gRNA sequence (saving a total of ~5.5 kb). These large-493 scale reductions thus provided us with room to upgrade our dual-modality tdTomato and FLuc2 494 reporter gene construct we previously reported 32 to a trimodality reporter gene construct with the 495 addition of the Oatp1a1 MRI reporter 42,43 . To improve safety and translatability we also removed 496 the puromycin resistance gene to reduce the MC size by a further 600 bp and utilized FACS of 497 tdTomato positive cells to obtain mixed and clonal cell populations instead of antibiotic 498 selection. Our final step for improving safety was to design our system to target a "safe harbour" 499 locus in genomic DNA. Several of these loci have now been reported in the literature 48 and are 500 described as sites where inserted genetic elements can function as intended, without causing 501 alterations that would pose a risk to the host cell or organism 23 . For this study we targeted the 502 AAVS1 site found within the human Protein Phosphatase 1 Regulatory Subunit 12C gene as this 503 has been one of the best characterized, to date. No known side effects are associated with 504 disrupting the PP1R12C gene, however it has been reported that mechanisms such as DNA 505 methylation can silence transgenes targeted to this genomic region 49 . Since our studies rely on 506 stable reporter gene expression over time for accurate cell detection and proliferation, we 507 investigated whether reporter gene expression in our AAVS1 engineered 293T-HITI and PC3-508 HITI cell populations changed over time. We found that BLI signal was stable over several 509 passages and tdT fluorescence was consistently expressed in both cell lines, indicating consistent 510 transgene expression. 511
512
We have shown here that HITI-based CRISPR/Cas9 cell engineering is more efficient than the 513 more commonly used HDR method for integrating large DNA donor constructs into the genome 514 for stable expression. Targeted transgene integration is typically achieved using homologous 515 arms and the HDR pathway, however, this mechanism is highly inefficient and is not usually 516 active in non-dividing cells 33 . Indeed, our previous study showed only 3.8% of selected cells 517 were correctly edited using the HDR mechanism 32 . In contrast, the HITI method which utilizes 518 the NHEJ pathway is active in all stages of the cell cycle and in quiescent cells 36 , and thus has 519 been used to improve editing efficiency. Using the method described by Suzuki et al. 38 , our 520 engineered 293T and PC3 clonal cell populations did indeed have greater DNA integration at the 521 AAVS1 site compared with HDR (36% and 12% for HITI vs 10.5% and 0% for HDR, 522 respectively). However, it is important to note that the NHEJ repair pathway is error prone and 523 often leads to insertions and deletions (indels) at the DNA junctions. Consequently, this 524 mechanism is often taken advantage of to produce DNA disruptions, gene silencing and knock-525 outs. These issues would need to be considered if using the HITI method for correctional DNA 526 editing and promoter-less vector integration, since these require specific DNA sequences, either 527 upstream or downstream, to be preserved. In this case, we engineered cells with the only 528 requirements being that the transgene inserts into the AAVS1 site (confirmed with junctional 529 PCR) and that the reporter genes are consistently expressed (confirmed with imaging). 530
Therefore, indels at either the 5' or 3' junction would likely have a negligible impact on our 531 experiments. 532
533
Although we confirmed correct transgene integration at the AAVS1 site in our study, we cannot 534 rule out integration at other off-target sites in HITI and HDR engineered populations. Several 535
293T and PC3 single-cell clonal populations expressed the tdTomato fluorescence reporter gene 536 but did not show integration bands for the AAVS1 site. Evidence suggests that CRISPR/Cas9 is 537 not 100% accurate and off-target effects have been reported 50,51 , thus, it is possible that the MCs 538 integrated into off-target Cas9 cut sites. However, it is also plausible, and probably more likely, 539 that the MCs inserted into the AAVS1 site in the wrong direction. Even though HITI is designed 540 to minimize integration in the wrong orientation, the error-prone NHEJ repair mechanism of 541 blunt-ended DNA breaks could lead to indels at the CRISPR/Cas9 cut site boundaries, which 542 could then disrupt the ability of Cas9 to recognize and re-cut those sites. The likelihood of indel 543 formation using Cas9 HITI could be reduced in future studies by adopting a similar method to 544 that recently reported by Li and colleagues 52 . In that study, the authors utilize Cas12a, which 545 leaves 5 bp overhangs, to precisely edit the genome in a process coined microhomology-546 dependent targeted integration (MITI) 52 . Independently of CRISPR, MCs, like plasmids, can also 547 randomly integrate into the genome of cells, albeit at very low rates. Future work will need to 548 analyze the rate of off-target integrations and possible indel disruptions at the CRISPR/Cas9 cut 549 sites using techniques, such as next generation sequencing, to determine the full safety profile of 550 HITI at safe harbour loci. To improve targeting specificity, studies have shown that high-fidelity 551 loading capacity of ~4.5 kb, which would be a problem for large, multimodality imaging vectors 557 as presented here, but conceivable for future studies where only one imaging reporter gene is 558 required. With these emerging technologies, it is likely that CRISPR gene editing will become 559 highly specific and thus safer in the near future. 560
561
We engineered cells with a multimodality reporter gene construct to enable us to go from single 562 cell, optical imaging methods (FLI) to higher sensitivity whole-animal planar imaging (BLI) and 563 superior 3D high-resolution tomographic imaging (MRI) in animals. This offers several 564 advantages. Firstly, fluorescently activated cell sorting of tdTomato-expressing cells improves 565 upon our previous study by eliminating the need for an antibiotic resistance selection gene, 566 which constitutes a safety risk and has been associated with structural plasmid instabilities 55 . 567
Secondly, the firefly luciferase gene (FLuc2), in combination with its substrate D-luciferin, 568 allowed us to directly visualize engineered cells in vivo using BLI. Inclusion of bioluminescent 569 genes in preclinical cancer models is a relatively inexpensive and valuable tool that also allows 570 one to track cell migration and cell seeding in metastatic cancer models, assess cell viability and 571 follow cell/tumour growth longitudinally 14 . A limitation of BLI is that it is restricted to small 572 animal models of disease. However, it is useful for determining sites of cell 573 arrest/seeding/growth and thus can be used in conjunction with other reporter genes as a guide 574 for determining when and where to perform relatively more expensive, higher resolution clinical 575 imaging, such as MRI 13 . To build off our previous dual FLI-BLI study 32 , we decided to include 576 the MRI reporter gene, Oatp1a1, as a translationally relevant and sensitive reporter gene to 577 complete our trimodality construct for HITI-based CRISPR engineering. First described by 578
Patrick et al. 42 , Oatp1a1 selectively, but reversibly, uptakes the clinically approved Gd 3+ contrast 579 agent Gd-EOB-DTPA and thus provides positive contrast in T1-weighted MR images. The 580 authors concluded, therefore, that Oatp1a1 engineered cells and tumours should be easier to 581 detect than the negative contrast generated by T2-agents, such as such as superparamagnetic iron 582 oxide (SPIO) and ferromagnetic agents 42,56 . In addition, engineering cells with integrated 583
Oatp1a1 expression means that MR images can be obtained longitudinally to track cell migration 584 and growth, and signal intensity can be directly correlated with cell viability. Finally, we and 585 others have found that Oatp1a1 also enhances the uptake of the firefly luciferase substrate D-586 luciferin for BLI 43,57 and the fluorescent dye indocyanine green (using the human ortholog 587 OATP1B3) for both fluorescent 58 and photoacoustic imaging 59 , which gives an added advantage 588 of using Oatp1 for multi-modality imaging. Since we, and others, have now shown that the 589 human OATP1B3 gene also functions as a useful fluorescent, photoacoustic and MRI reporter 590 gene, in vivo 58,59 , future studies will focus on exchanging Oatp1a1 for the more translationally 591 favourable OATP1B3 ortholog. 592
593
The improved safety profile and expression of multimodal reporter genes proposed here could 594 have several uses in cell engineering, or at least help answer several concerns with in vivo cell 595 therapies. For example, the U.S. Food and Drug Administration have listed potential safety 596 concerns related to unproven stem cell therapies 60 , including: 1) the ability of cells to move from 597 placement sites and change into inappropriate cell types or multiply; 2) failure of cells to work as 598 expected, and 3) the growth of tumours. In addition, the long-term safety profiles of cells 599 engineered with randomly-integrating viruses still require further investigation and optimization. 600
These are concerns that could be addressed by targeting non-viral DNA vectors, such as MCs, to specific safe-harbour loci, such as AAVS1, and reducing the use of integrating viruses. 602
Incorporating reporter genes for clinical grade imaging will also help improve patient safety by 603 allowing one to track cellular therapies in vivo (such as for stem cells and immunotherapies). 604
Clinicians could then determine whether the therapeutic cells are localizing to the correct 605 anatomical feature, such as a solid tumour 18 , or to determine their persistence and viability for 606 short-and long-term treatment strategies. Future work will focus on evaluating our system in 607 stem cells and other clinically relevant cell types. Translation will also need to consider building 608 donor vectors that lack optical reporter genes and utilize other selection methods (e.g., magnetic 609 sorting). It is easily feasible to switch out genes from our trimodality construct for other imaging 610 purposes, such as replacing FLuc2 with a PET reporter gene for dual PET-MR imaging. Suicide 611 switch genes could also be incorporated to further improve safety by killing the engineered cells 612 in cases where they become oncogenic 61 , for example. Not only are these tools useful for clinical 613 cell-based therapies, they are also extremely useful in pre-clinical studies for investigating cancer 614 progression/aggression, metastatic burden and treatment strategies. Avoiding the use of random-615
integrating viruses and targeted editing should also help reduce off-target effects of gene-editing 616 that may alter the normal characteristics of the cell type being studied. 617
618
Conclusion 619
Our work demonstrates the first CRISPR/Cas9 HITI MC system for safe harbor integration of a 620 large donor construct encoding three reporter genes for multi-modal longitudinal imaging of cells 621 in vivo. We have shown that inclusion of the translationally relevant MR reporter gene, Oatp1a1, 622
can enable localization and tracking of small primary and metastatic tumours that are not readily 623 detectable visually or in pre-contrast MR images. This work lays the foundation for an effective 624 and safer genome editing tool for non-invasive reporter gene tracking of multiple cell types in 625 vivo, such as for cell-based cancer immunotherapies and stem cell treatments. integration checks at the AAVS1 site. GAPDH was amplified as a DNA loading control. B, 808
Quantification shows a higher number of positive integration clones for HITI engineered cells 809 compared to HDR for both 293T and PC3 cell lines. 810 passages. E and K, Spin-lattice relaxation maps of representative phantoms containing pellets of 815 cells untreated or treated with 6.4 mM Gd-EOB-DTPA, as follows: 1, naive, treated; 2, naïve 816 untreated; 3, HITI treated; 4, HITI untreated. F and L, quantification of spin-lattice rates (n = 3, 817 *** P < 0.001). 818 subcutaneously into five locations on the back of nude mice, with increasing concentrations of 821 HITI engineered cells, as indicated in yellow, and corresponding BLI signals. B, quantification of 822 BLI signal from ROIs around the five PC3 injection sites. C, MRI transverse views of cell injection 823 sites 5 hours after Gd-EOB-DTPA injection. D, quantification of contrast-to-noise (CNR) ratio for 824 10 6 and 3x10 6 PC3-HITI cells. Note, 10 4 and 10 5 PC3-HITI injections lacked enough contrast to 825 measure CNR values. n = 3 mice, * P < 0.05, ** P < 0.01, *** P < 0.001. 826 subcutaneously with 1x10 6 naïve and PC3-HITI cells on the left and right flanks, respectively. BLI 829 signal was present on right flank only. Naïve tumour locations are denoted by black dashed line. 830
A, day 11 post PC3 injection. 2D and maximum intensity projection (MIP) images acquired 5 hrs 831
post Gd-EOB-DTPA injection. B, the same mouse was re-imaged at day 46. Pre-, 20min post-and 832 5hr post-contrast coronal images were obtained. C, contrast-to-noise ratios (CNR) of PC3-HITI 833 tumours 5hr post-contrast showed significant increase from day 11 to day 46. n = 4 (day 11) and 834 n = 3 (day 46) * P < 0.05. 835 836 837 838 Figure 6 . In vivo MRI detection of metastatic PC3-HITI tumours. A, The brightest BLI signal 839 corresponded to a tumour in the liver, which is evident as a shadow in pre-contrast images and as 840 a bright positive Gd-EOB-DTPA contrast tumour in images taken 5 hrs post-contrast injection. B, 841
A mouse showed BLI signal in the head region, which was not evident in pre-contrast MIP and 842
2D transverse MRI slices (upper panel). However, clusters of PC3-HITI tumours were easily 843 discernible in 5hr post-contrast images (yellow arrows, lower panel). 844 845
